(Press-News.org) Acting on a proposal from the Institut Pasteur President Yasmine Belkaid, the Institut Pasteur Board of Governors appointed Mariana Mesel-Lemoine as Director of Diversity, Equity and Inclusion on Wednesday February 7, 2024.
This appointment marks a significant milestone in the history of the Institut Pasteur, and it is the first French research institute to establish a position of this kind at such a senior and strategic level. Mariana Mesel-Lemoine will report directly to the President. Her mission will be to propose policy and strategy priorities related to diversity, equity and inclusion for the "Pasteur 2030" Strategic Plan, to oversee their implementation and to support the organizational changes that they require. She will work in close collaboration with the various Institut Pasteur departments and the Employee Resources Groups to guarantee that these basic principles are integrated into all aspects of life and work at the Institut Pasteur.
Mariana Mesel-Lemoine took her first steps in science at the Oswaldo Cruz Foundation in Brazil, focusing her early research on plague and filariasis. She left Brazil in 1997 and came to France, where she completed a Master's and a PhD in Immunology, specializing in graft-versus-host disease at Pitié-Salpêtrière hospital in Paris. She joined the Institut Pasteur in 2006 for a postdoctoral fellowship in virology. Her passion for science soon led her to turn her attention to the people involved in science, and she became keen to support her fellow scientists and guide them in their professional development. In 2014, Mariana Mesel-Lemoine therefore set out to establish the Office in charge of Integration and Career Guidance Structure for Scientists (MAASCC), now the Career Development Service for Scientists at the Institut Pasteur, or CARE. This body, the only one of its kind in France, has provided support for nearly 2,000 scientists over the past decade and proposed practical solutions to address some of the worrying phenomena observed in French research, like the declining interest in science and the loss of female talent. In response to these challenges, Mariana Mesel-Lemoine has developed and implemented cross-cutting projects involving several departments and the Institut Pasteur community. These initiatives have led to major achievements such as the European HR Excellence in Research Award in 2021 and the publication of a Gender Equality Plan (GEP) in 2022.
It is with immense joy and a strong sense of commitment that I am taking on the role of Director of Diversity, Equity and Inclusion at the Institut Pasteur. The Institut Pasteur community is a rich tapestry of different talents, backgrounds, perspectives and experiences. By embracing our diversity and valuing what makes us unique, the Institut Pasteur will strengthen its ability to innovate and to tackle major public health challenges.
Mariana Mesel-Lemoine, Director of Diversity, Equity and Inclusion
The appointment of Mariana Mesel-Lemoine, which comes just a few days before the International Day of Women and Girls in Science on February 11, emphasizes the Institut Pasteur's commitment to improving the representation of women in senior positions in the research sector and advancing the role and visibility of women in science. There continue to be glaring inequalities for women in research. The proportion of women in senior leadership positions was 32.2% in 2023 (Gender Gap Report, 2023). Women represented just 27% of research directors and 19% of university professors in science in 2019 (Rapport de situation comparée entre les femmes et les hommes, CNRS, 2019). Women are most likely to be under-represented as authors of scientific publications, they have a lower grant application success rate and they represent just 10.7% of patent holders at EU level (She Figures, 2021).
END
Mariana Mesel-Lemoine appointed as Director of Diversity, Equity and Inclusion at the Institut Pasteur
2024-02-09
ELSE PRESS RELEASES FROM THIS DATE:
Time to anticoagulation reversal and outcomes after intracerebral hemorrhage
2024-02-09
About The Study: In hospitals participating in Get With The Guidelines–Stroke, earlier anticoagulation reversal was associated with improved survival for patients with intracerebral hemorrhage. These findings support intensive efforts to accelerate evaluation and treatment for patients with this devastating form of stroke.
Authors: Kevin N. Sheth, M.D., of the Yale University School of Medicine in New Haven, Connecticut, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this ...
Data shows significant prevalence of sleep apnea among cardio-oncology patients
2024-02-09
Sleep apnea is prevalent among cardio-oncology patients who are at higher risk for congestive heart failure from cancer therapy, according to a new study being presented at the American College of Cardiology (ACC) Advancing the Cardiovascular Care of the Oncology Patient course.
Sleep apnea is a disorder of altered breathing while asleep with two types, obstructive (OSA) or central (CSA). Both can be treated to alleviate symptoms and improve cardiovascular outcomes. This study pertains to obstructive sleep apnea. A well-established screening tool for detecting sleep apnea is the STOP-BANG questionnaire utilizing eight questions using ...
Emergence of SARS-CoV-2 variant JN.1 raises concerns with increased transmissibility and immune evasion
2024-02-09
Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a worldwide threat. The emergence of the BA.2.86 variant, a subvariant of Omicron, has raised significant concerns due to its substantial number of mutations. Discovered in August 2023, this variant differs markedly from other existing types such as Omicron XBB (including EG.5.1 and HK.3). Compared with XBB and BA.2, BA.2.86 exhibits more than 30 mutations in its spike protein, contributing to its ability to effectively evade the immune system’s defenses.
Over ...
Temperature-sensitive prosthetic limb improves amputee dexterity and feelings of human connection
2024-02-09
Sensory feedback is important for amputees to be able to explore and interact with their environment. Now, researchers have developed a device that allows amputees to sense and respond to temperature by delivering thermal information from the prosthesis’ fingertip to the amputee’s residual limb. The “MiniTouch” device, presented February 9 in the journal Med, uses off-the-shelf electronics, can be integrated into commercially available prosthetic limbs, and does not require surgery. Using the thermally sensitive prosthetic hand, ...
Towards a natural prosthetic hand: A study published in Med has developed a temperature-sensitive prosthetic limb that improves amputee interactions and feelings of human connection
2024-02-09
Pisa, 9 February 2024. “When one of the researchers placed the sensor on his own body, I could feel the warmth of another person with my phantom hand. it was a very strong emotion for me, it was like reactivating a connection with someone”.
Thanks to a sensorised prosthetic hand that provides realistic and real-time thermal feedback, Fabrizio, a 57-year-old man from Pistoia with a transradial (wrist) amputation, was able to discriminate between and manually sort objects of different temperatures or materials and ...
Making AI a partner in neuroscientific discovery
2024-02-09
The past year has seen major advances in Large Language Models (LLMs) such as ChatGPT. The ability of these models to interpret and produce human text sources (and other sequence data) has implications for people in many areas of human activity. A new perspective paper in the journal Neuron argues that like many professionals, neuroscientists can either benefit from partnering with these powerful tools or risk being left behind.
In their previous studies, the authors showed that important preconditions are met to develop LLMs that can interpret and analyze neuroscientific data like ChatGPT interprets language. These AI models can be built for many different types ...
Changes in outpatient health care use after COVID-19 infection among veterans
2024-02-09
About The Study: This study including 202,000 veterans with COVID-19 and 202,000 matched uninfected veterans found that outpatient use increased significantly in the month after infection, then attenuated but remained greater than the uninfected cohorts’ use through 12 months, which suggests that there are sustained impacts of COVID-19 infection.
Authors: Matthew L. Maciejewski, Ph.D., of the Durham Veterans Affairs Health Care System in Durham, North Carolina, is the corresponding author.
To access the embargoed study: Visit our For The Media ...
Long-term brain structure and cognition following bariatric surgery
2024-02-09
About The Study: The findings of this study including 133 adults with severe obesity suggest that bariatric surgery was associated with health benefits two years after surgery. Bariatric surgery was associated with improved cognition and general health and changed blood vessel efficiency and cortical thickness of the temporal cortex. These results may improve treatment options for patients with obesity and dementia.
Authors: Amanda J. Kiliaan, Ph.D., of the Radboud University Medical Center, Donders Institute for Brain, Cognition, ...
Pioneering technique reveals new layer of human gene regulation
2024-02-09
A technique can determine for the first time how frequently, and exactly where, a molecular event called “backtracking” occurs throughout the genetic material (genome) of any species, a new study shows.
Published online February 9 in Molecular Cell, the study results support the theory that backtracking represents a widespread form of gene regulation, which influences thousands of human genes, including many involved in basic life processes like cell division and development in the womb.
Led by researchers from NYU Grossman School of Medicine, the work revolves around genes, the stretches ...
Reducing diabetes medication costs can help improve outcomes, especially for low-income patients
2024-02-09
BOSTON, MA — A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that reducing out-of-pocket costs for patients with diabetes, especially those considered low income, can be one step toward improving health outcomes.
The study, “Acute Diabetes Complications After Transition to a Value-Based Medication Benefit,” was published in the February 9 edition of JAMA Health Forum.
Treatment with antidiabetic agents, antihypertensives, and lipid-lowering ...